Evidence map›Paper›PMID 33808150›Full record

ArticleInternational journal of molecular sciences2021

The Pro-Apoptotic Effect of Silica Nanoparticles Depends on Their Size and Dose, as Well as the Type of Glioblastoma Cells.

Rafał Krętowski, Magdalena Kusaczuk, Monika Naumowicz, Marzanna Cechowska-Pasko

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rafał KrętowskiDepartment of Pharmaceutical Biochemistry, Medical University of Bialystok, 15-089 Bialystok, Poland.
Magdalena KusaczukDepartment of Pharmaceutical Biochemistry, Medical University of Bialystok, 15-089 Bialystok, Poland.
Monika NaumowiczInstitute of Chemistry, University in Bialystok, 15-328 Bialystok, Poland.ORCID 0000-0001-5229-1805
Marzanna Cechowska-PaskoDepartment of Pharmaceutical Biochemistry, Medical University of Bialystok, 15-089 Bialystok, Poland.ORCID 0000-0002-2806-399X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite intensive investigations, nanoparticle-induced cellular damage is an important problem that has not been fully elucidated yet. Here, we report that silica nanoparticles (SiNPs) demonstrated anticancer influence on glioblastoma cells by the induction of apoptosis or necrosis. These effects are highly cell type-specific, as well as dependent on the size and dose of applied nanoparticles. Exposure of LN-18 and LBC3 cells to different sizes of SiNPs-7 nm, 5-15 nm, or 10-20 nm-at dosages, ranging from 12.5 to 1000 µg/mL, for 24 and 48 h reduced the viability of these cells. Treatment of LN-18 and LBC3 cells with 7 nm or 10-20 nm SiNPs at doses ≥50 µg/mL caused a strong induction of apoptosis, which is connected with an increase of intracellular reactive oxygen species (ROS) production. The 5-15 nm SiNPs exhibited distinct behavior comparing to silica nanoparticles of other studied sizes. In contrast to LBC3, in LN-18 cells exposed to 5-15 nm SiNPs we did not observe any effect on apoptosis. These nanoparticles exerted only strong necrosis, which was connected with a reduction in ROS generation. This suggests that SiNPs can trigger different cellular/molecular effects, depending on the exposure conditions, the size and dose of nanoparticles, and cell type of glioblastoma.

Indexed as

Antineoplastic AgentsApoptosisCell Line, TumorCell SurvivalFemaleGlioblastomaHumansMiddle AgedNanoparticlesNecrosisOxidative StressParticle SizeReactive Oxygen SpeciesSilicon DioxideAntineoplastic AgentsReactive Oxygen SpeciesSilicon Dioxideapoptosisglioblastomananotoxicitysilica nanoparticles

Identifiers

PMID33808150
PMCPMC8037515

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.